Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Biochemistry|May 1, 1994
Diversity in the processing events at the N-terminus of type-V collagenM Moradi-Améli, J C Rousseau, J P Kleman, et al.
Journal of Animal Breeding and Genetics = Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie|January 9, 2014
Effect of allele frequencies, effect sizes and number of markers on prediction of quantitative traits in chickensR Abdollahi-Arpanahi, A Nejati-Javaremi, A Pakdel, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 15, 2010
Phylogenetic analysis in a recent controlled outbreak of Crimean-Congo haemorrhagic fever in the south of Iran, December 2008S Chinikar, S M Ghiasi, S Mojtaba Ghiasi, et al.
Journal of Animal Breeding and Genetics = Zeitschrift Fur Tierzuchtung Und Zuchtungsbiologie|January 28, 2014
Dissection of additive genetic variability for quantitative traits in chickens using SNP markersR Abdollahi-Arpanahi, A Pakdel, A Nejati-Javaremi, et al.
Archives of Microbiology|December 13, 2022
Diversity of actinomycete and their metabolites isolated from Howz Soltan Lake, IranE Salehghamari, M Moradi, M Sardabi, et al.
Transboundary and Emerging Diseases|August 1, 2008
Surveillance and laboratory detection system of Crimean-Congo haemorrhagic fever in IranS Chinikar, M M Goya, M R Shirzadi, et al.
European Journal of Neurology|April 22, 2019
Burden of neurodegenerative diseases in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease Study 2016S-M Fereshtehnejad, K Vosoughi, P Heydarpour, et al.
Public Health|August 10, 2020
The mortality rate from self-harm in IranZ Ghodsi, S S Moghaddam, P Vezvaei, et al.
Pediatric Hematology and Oncology|September 6, 2007
Bone mineral density in Iranian adolescents and young adults with beta-thalassemia majorA A Shamshirsaz, M R Bekheirnia, M Kamgar, et al.
Journal for Immunotherapy of Cancer|June 23, 2016
Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trialH J Gray, B Benigno, J Berek, et al.
Pageof 13